Population-Based Prevalence of Myotonic Dystrophy Type 1 Using Genetic Analysis of Statewide Blood Screening Program

Nicholas E Johnson1,2, Russell J Butterfield3,4, Katie Mayne3,4

  • 1From the Department of Neurology (N.E.J.), Virginia Commonwealth University, Richmond; and Departments of Pediatrics (R.J.B., K.M., T.N., C.I., M.L.F.) and Nicholas.johnson@vcuhealth.org.

Neurology
|January 21, 2021
PubMed
Summary

The genetic prevalence of myotonic dystrophy type 1 (DM1) is up to five times higher than previously estimated. This finding suggests that DM1 is likely underdiagnosed, highlighting the need for increased awareness and diagnostic efforts.

Related Concept Videos